Avior Wealth Management’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-367
| Closed | -$15.3K | – | 1730 |
|
|
2024
Q4 | $15.3K | Sell |
367
-2,284
| -86% | -$95K | ﹤0.01% | 1490 |
|
|
2024
Q3 | $177K | Sell |
2,651
-196
| -7% | -$13.1K | 0.01% | 731 |
|
|
2024
Q2 | $338K | Sell |
2,847
-267
| -9% | -$31.7K | 0.01% | 536 |
|
|
2024
Q1 | $332K | Buy |
3,114
+296
| +11% | +$31.5K | 0.02% | 554 |
|
|
2023
Q4 | $280K | Sell |
2,818
-279
| -9% | -$27.7K | 0.02% | 464 |
|
|
2023
Q3 | $320K | Buy |
3,097
+2,129
| +220% | +$220K | 0.02% | 431 |
|
|
2023
Q2 | $118K | Buy |
968
+783
| +423% | +$95.1K | 0.01% | 605 |
|
|
2023
Q1 | $28.4K | Hold |
185
| – | – | ﹤0.01% | 887 |
|
|
2022
Q4 | $33.2K | Hold |
185
| – | – | ﹤0.01% | 686 |
|
|
2022
Q3 | $21K | Hold |
185
| – | – | ﹤0.01% | 732 |
|
|
2022
Q2 | $26K | Sell |
185
-54
| -23% | -$7.59K | ﹤0.01% | 645 |
|
|
2022
Q1 | $41K | Buy |
239
+10
| +4% | +$1.72K | ﹤0.01% | 625 |
|
|
2021
Q4 | $58K | Hold |
229
| – | – | ﹤0.01% | 568 |
|
|
2021
Q3 | $88K | Buy |
229
+175
| +324% | +$67.2K | 0.01% | 503 |
|
|
2021
Q2 | $12K | Sell |
54
-30
| -36% | -$6.67K | ﹤0.01% | 729 |
|
|
2021
Q1 | $10K | Buy |
84
+54
| +180% | +$6.43K | ﹤0.01% | 761 |
|
|
2020
Q4 | $3K | Sell |
30
-33
| -52% | -$3.3K | ﹤0.01% | 846 |
|
|
2020
Q3 | $4K | Hold |
63
| – | – | ﹤0.01% | 767 |
|
|
2020
Q2 | $4K | Hold |
63
| – | – | ﹤0.01% | 737 |
|
|
2020
Q1 | $1K | Buy |
+63
| New | +$1K | ﹤0.01% | 735 |
|